Nils Burger

Nils Burger

Auto-generated profile, based on publicly available information

Nils Burger

Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2023 in Nature
Verified
Journal Article
Closed access
PDF file
WLWeihai Liu
Weihai Liu
YWYun Wang
Yun Wang
LBLuiz H. M. Bozi
Luiz H. M. Bozi
PFPatrick D. Fischer
Patrick D. Fischer
MJMark P. Jedrychowski
Mark P. Jedrychowski
ECEdward T. Chouchani
Edward T. Chouchani

29 January 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZYZhan Yin
Zhan Yin
NBNils Burger
Nils Burger
DKDuvaraka Kula-Alwar
Duvaraka Kula-Alwar
DADunja Aksentijevic
Dunja Aksentijevic
HBHannah R. Bridges
Hannah R. Bridges
JHJudy Hirst
Judy Hirst
Mitochondrial complex I is central to the pathological reactive oxygen species (ROS) production that underlies cardiac ischemia–reperfusion (IR) injury. ND6-P25L mice are homoplasmic for a disease-causing mtDNA point mutation encoding the P25L substitution in the ND6 subunit of complex I. The cryo-EM structure of ND6-P25L complex I revealed subtle structural changes that facilitate rapid conversion to the “deactive” state, usually formed only after prolonged inactivity. Despite its tendency to adopt the “deactive” state, the mutant complex is fully active for NADH oxidation, but cannot generate ROS by reverse electron transfer (RET). ND6-P25L mitochondria function normally, except for their lack of RET ROS production, and ND6-P25L mice are protected against cardiac IR injury in vivo. Thus, this single point mutation in complex I, which does not affect oxidative phosphorylation but renders the complex unable to catalyse RET, demonstrates the pathological role of ROS production by RET during IR injury.

5 April 2022 in Journal of the American Chemical Society
Verified
Journal Article
Open access
JWJohn J. Wright
John J. Wright
OBOlivier Biner
Olivier Biner
ICInjae Chung
Injae Chung
NBNils Burger
Nils Burger
HBHannah R. Bridges
Hannah R. Bridges
JHJudy Hirst
Judy Hirst
Respiratory complex I is an essential metabolic enzyme that uses the energy from NADH oxidation and ubiquinone reduction to translocate protons across an energy transducing membrane and generate the proton motive force for ATP synthesis. Under specific conditions, complex I can also catalyze the reverse reaction, Δp-linked oxidation of ubiquinol to reduce NAD+ (or O2), known as reverse electron transfer (RET). Oxidative damage by reactive oxygen species generated during RET underpins ischemia reperfusion injury, but as RET relies on several converging metabolic pathways, little is known about its mechanism or regulation. Here, we demonstrate Δp-linked RET through complex I in a synthetic proteoliposome system for the first time, enabling complete kinetic characterization of RET catalysis. We further establish the capability of our system by showing how RET in the mammalian enzyme is regulated by the active-deactive transition and by evaluating RET by complex I from several species in which direct assessment has not been otherwise possible. We thus provide new insights into the reversibility of complex I catalysis, an important but little understood mechanistic and physiological feature.

31 December 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
RCRenee B. Chang
Renee B. Chang
HTHunter C. Toyoda
Hunter C. Toyoda
SHSamuel J. Hobbs
Samuel J. Hobbs
DRDesmond Richmond-Buccola
Desmond Richmond-Buccola
TWTanita Wein
Tanita Wein
PKPhilip J. Kranzusch
Philip J. Kranzusch
Summary: Cyclic oligonucleotide-based antiviral signaling systems (CBASS) are bacterial anti-phage defense operons that use nucleotide signals to control immune activation. Here we biochemically screen 57 diverse E. coli and Bacillus phages for the ability to disrupt CBASS immunity and discover anti-CBASS 4 (Acb4) from the Bacillus phage SPO1 as the founding member of a large family of >1,300 immune evasion proteins. A 2.1 Å crystal structure of Acb4 in complex with 3′3′-cGAMP reveals a tetrameric assembly that functions as a sponge to sequester CBASS signals and inhibit immune activation. We demonstrate Acb4 alone is sufficient to disrupt CBASS activation in vitro and enable immune evasion in vivo . Analyzing phages that infect diverse bacteria, we explain how Acb4 selectively targets nucleotide signals in host defense and avoids disruption of cellular homeostasis. Together, our results reveal principles of immune evasion protein evolution and explain a major mechanism phages use to inhibit host immunity.

27 July 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
DRDylan G. Ryan
Dylan G. Ryan
MYMing Yang
Ming Yang
HPHiran A. Prag
Hiran A. Prag
GBGiovanny Rodriguez Blanco
Giovanny Rodriguez Blanco
ENEfterpi Nikitopoulou
Efterpi Nikitopoulou
CFChristian Frezza
Christian Frezza
Summary: The Tricarboxylic Acid Cycle (TCA) cycle is arguably the most critical metabolic cycle in physiology and exists as an essential interface coordinating cellular metabolism, bioenergetics, and redox homeostasis. Despite decades of research, a comprehensive investigation into the consequences of TCA cycle dysfunction remains elusive. Here, we targeted two TCA cycle enzymes, fumarate hydratase (FH) and succinate dehydrogenase (SDH), and combined metabolomics, transcriptomics, and proteomics analyses to fully appraise the consequences of TCA cycle inhibition (TCAi) in kidney epithelial cells. Our comparative approach shows that TCAi elicits a convergent rewiring of redox and amino acid metabolism dependent on the activation of ATF4 and the integrated stress response (ISR). Furthermore, we also uncover a divergent metabolic response, whereby acute FHi, but not SDHi, can maintain asparagine levels via reductive carboxylation and maintenance of cytosolic aspartate synthesis. Our work highlights an important interplay between the TCA cycle, redox biology and amino acid homeostasis. Highlights: TCA cycle inhibition promotes GSH synthesis and impairs de novo aspartate and proline synthesis Disruption of mitochondrial thiol redox homeostasis phenocopies TCA cycle inhibition by promoting GSH synthesis and impairing proline and aspartate synthesis Acute FHi, but not SDHi, can maintain asparagine levels via reductive carboxylation and maintenance of cytosolic aspartate synthesis TCA cycle inhibition mimics an amino acid deprivation-type response and activates ATF4 via the integrated stress response to maintain redox and amino acid homeostasis